These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10577495)

  • 1. Withdrawal of rotavirus vaccine recommendation.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):1007. PubMed ID: 10577495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):786-9. PubMed ID: 15343145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation.
    JAMA; 1999 Dec; 282(22):2113-4. PubMed ID: 10591321
    [No Abstract]   [Full Text] [Related]  

  • 5. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Mar; 48(RR-2):1-20. PubMed ID: 10219046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines--an update.
    Dennehy PH
    Vaccine; 2007 Apr; 25(16):3137-41. PubMed ID: 17321017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G; Ferrarini G; Rigolin F; Bogaerts H; André FE
    Helv Paediatr Acta; 1986 Aug; 41(3):203-8. PubMed ID: 3019954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.